Castleark Management’s Core Laboratories CLB Stock Holding History

Castleark Management’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-28,580	Closed	-$5.67M	–	349
2014 Q3	$5.67M	Buy	28,580 +21,435	+300%	+$3.31M	0.16%	144
2014 Q2	$1.19M	Sell	7,145 -21,435	-75%	-$3.81M	0.03%	233
2014 Q1	$5.67M	Buy	28,580 +15,000	+110%	+$2.83M	0.16%	144
2013 Q4	$2.59M	Buy	+13,580	New	+$2.53M	0.08%	197
2013 Q3	–	Sell	-13,580	Closed	-$2.06M	–	355
2013 Q2	$2.06M	Buy	+13,580	New	+$1.92M	0.07%	191

Other funds holding CLB

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Wedgewood Partners St Louis, Missouri $484M AUM 14.59% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Castleark Management's CLB Position: Q4 2014 in Review

Castleark Management sold out of Core Laboratories (CLB) in Q4 2014, closing a stake of 28,580 shares — an estimated $5.67M sold.

Castleark Management first reported a position in CLB in Q2 2013 and held it in 5 quarters. The position peaked at $5.67M in Q3 2014. 345 funds tracked by Wall St. Rank hold CLB as of Q4 2014.

Castleark Management reported no remaining Core Laboratories position as of Q4 2014 after selling out during the quarter.
Castleark Management sold 28,580 Core Laboratories shares in Q4 2014, an estimated $5.67M.
Castleark Management first reported a position in Core Laboratories in Q2 2013 and held it in 5 quarters.
Castleark Management's Core Laboratories position peaked at $5.67M in Q3 2014.
345 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2014.

Based on Castleark Management's 13F filing for Q4 2014, filed 10 Feb 2015.